|
1
|
Grubisa I, Jankovic M, Nikolic N, Jaksic V, Risimic D, Mavija M, Stamenkovic M, Zlatovic M, Milasin J. Novel TEAD1 gene variant in a Serbian family with Sveinsson's chorioretinal atrophy. Exp Eye Res 2021; 207:108575. [PMID: 33864784 DOI: 10.1016/j.exer.2021.108575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Revised: 03/22/2021] [Accepted: 04/08/2021] [Indexed: 10/21/2022]
Abstract
Sveinsson's chorioretinal atrophy (SCRA) or helicoidal peripapillary chorioretinal degeneration (HPCD) as previously referred, is a rare ocular disease with autosomal dominant pattern of inheritance. The vast majority of reported cases were of Icelandic origin but the characteristic clinical picture of SCRA was also described in patients of non-Icelandic descent. Here, we report a novel disease-causing variant c.1261T>A, p.Tyr421Asn in TEAD1, detected in a Serbian family from Bosnia diagnosed with SCRA. The newly discovered change occurred at the same position as the "Icelandic mutation" (c.1261T>C, p.Tyr421His). According to our findings, this position in the exon 13 of the TEAD1 gene, at base pair 94, should be considered as a mutation hotspot and a starting point for future genetic analyses of patients with SCRA diagnosis.
Collapse
Affiliation(s)
- Ivana Grubisa
- Department of Human Genetics, Zvezdara University Medical Center, University of Belgrade, Dimitrija Tucovića 161, 11000, Belgrade, Serbia.
| | - Milena Jankovic
- Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotića Starijeg 6, 11000, Belgrade, Serbia.
| | - Nadja Nikolic
- Department of Biology and Human Genetics, School of Dental Medicine, University of Belgrade, Dr Subotića 1, 11000, Belgrade, Serbia.
| | - Vesna Jaksic
- Faculty of Medicine, University of Belgrade, Dr Subotića 8, 11000, Belgrade, Serbia; University Eye Clinic Zvezdara, University of Belgrade, Dismitrija Tucovića 161, 11000, Belgrade, Serbia.
| | - Dijana Risimic
- Faculty of Medicine, University of Belgrade, Dr Subotića 8, 11000, Belgrade, Serbia.
| | - Milka Mavija
- Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000, Banja Luka, Bosnia and Herzegovina.
| | - Miroslav Stamenkovic
- University Eye Clinic Zvezdara, University of Belgrade, Dismitrija Tucovića 161, 11000, Belgrade, Serbia.
| | - Mario Zlatovic
- Faculty of Chemistry, University of Belgrade, Studentski Trg 12-16, 11000, Belgrade, Serbia.
| | - Jelena Milasin
- Department of Biology and Human Genetics, School of Dental Medicine, University of Belgrade, Dr Subotića 1, 11000, Belgrade, Serbia.
| |
Collapse
|
|
2
|
Bokhovchuk F, Mesrouze Y, Izaac A, Meyerhofer M, Zimmermann C, Fontana P, Schmelzle T, Erdmann D, Furet P, Kallen J, Chène P. Molecular and structural characterization of a
TEAD
mutation at the origin of Sveinsson's chorioretinal atrophy. FEBS J 2019; 286:2381-2398. [DOI: 10.1111/febs.14817] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2019] [Revised: 02/19/2019] [Accepted: 03/21/2019] [Indexed: 12/17/2022]
Affiliation(s)
- Fedir Bokhovchuk
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Yannick Mesrouze
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Aude Izaac
- Chemical Biology & Therapeutics Novartis Institutes for Biomedical Research Basel Switzerland
| | - Marco Meyerhofer
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Catherine Zimmermann
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Patrizia Fontana
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Tobias Schmelzle
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Dirk Erdmann
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| | - Pascal Furet
- Global Discovery Chemistry Novartis Institutes for Biomedical Research Basel Switzerland
| | - Joerg Kallen
- Chemical Biology & Therapeutics Novartis Institutes for Biomedical Research Basel Switzerland
| | - Patrick Chène
- Disease Area Oncology Novartis Institutes for Biomedical Research Basel Switzerland
| |
Collapse
|